TELA Bio (TELA) Change in Accured Expenses (2018 - 2026)
TELA Bio has reported Change in Accured Expenses over the past 8 years, most recently at $663000.0 for Q4 2025.
- For Q4 2025, Change in Accured Expenses rose 178.74% year-over-year to $663000.0; the TTM value through Dec 2025 reached $1.8 million, up 197.29%, while the annual FY2025 figure was $1.8 million, 197.29% up from the prior year.
- Change in Accured Expenses for Q4 2025 was $663000.0 at TELA Bio, up from $633000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.8 million in Q4 2023 and troughed at -$3.5 million in Q1 2024.
- A 5-year average of $460000.0 and a median of $935000.0 in 2021 define the central range for Change in Accured Expenses.
- Biggest five-year swings in Change in Accured Expenses: skyrocketed 1136.53% in 2021 and later tumbled 130.03% in 2024.
- Year by year, Change in Accured Expenses stood at $1.1 million in 2021, then surged by 43.88% to $1.6 million in 2022, then skyrocketed by 75.25% to $2.8 million in 2023, then tumbled by 130.03% to -$842000.0 in 2024, then skyrocketed by 178.74% to $663000.0 in 2025.
- Business Quant data shows Change in Accured Expenses for TELA at $663000.0 in Q4 2025, $633000.0 in Q3 2025, and $1.4 million in Q2 2025.